HIV research has led to groundbreaking treatments, turning the virus from a fatal disease into a manageable condition, with ...

This issue highlights a broader concern regarding medication coverage and affordable health care. It underscores the critical ...

Ending HIV Together: Michigan’s Equitable Plan aims to reduce new HIV infections by 90% by 2030. Aligned with the U.S.

On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-U.S. (IAS-U.S.) has ...

U.S. drugmaker Merck said on Thursday its experimental combination treatment for some adults with HIV-1 infection met the ...

HIV encephalopathy, a severe brain complication of HIV/AIDS, affects memory and cognition. Expert stresses early intervention ...

HIV stigma and discrimination continue to harm the lives of people living with HIV, and hinder efforts to stem the epidemic ...

As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...

On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has ...

Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...

Merck shares Phase 3 trial results for its HIV-1 regimen, doravirine/islatravir, showing safety and comparable efficacy to ...

What does the HIV response look like beyond the 2030 targets to end AIDS? For the past year, UNAIDS has been working with ...